Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/12/022443
CTRI/2019/12/022443
Active, not recruiting
Phase 1

A PROSPECTIVE TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF THE g-STEAM (SCLERAL TRANSLOCATION ELASTO-MODULATION) PROCEDURE FOR THE TREATMENT OF PRIMARY GLAUCOMA IN INDIAN ADULTS

ALeyeGN Technologies LLC0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: H402- Primary angle-closure glaucoma

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: H402- Primary angle-closure glaucoma
Sponsor
ALeyeGN Technologies LLC
Status
Active, not recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
ALeyeGN Technologies LLC

Eligibility Criteria

Inclusion Criteria

  • •First Phase:
  • •1\. Male and female subjects are eligible for the study if they are 18 years old or older and have given written informed consent
  • •2\. Low visual potential BCDVA \< 2/60
  • •3\. Having primary or secondary glaucoma with no or low visual potential and high IOP / or on treatment for the same
  • •Second Phase:
  • •1\. Male and female subjects are eligible for the study if they are 18 years old or older and 80 years old or less and have given informed consent
  • •2\. Subject with OHT or POAG with IOP 18\- 35 mmHg
  • •3\. May include PACG after YAG PI (Iridotomy patency and location documented) and requiring medical management.
  • •4\. Requiring one or more anti\-glaucoma medication for IOP control
  • •5\. Noncompliance, poor control or intolerability/allergy to topical hypotensive treatments

Exclusion Criteria

  • •First Phase:
  • •1\. Patients younger than 18 years or older than 80 years
  • •2\. Sighted patients BCDVA \>2/60
  • •3\. Known allergy to involved topical medications
  • •4\. Severe systemic disease (i.e. uncontrolled diabetes mellitus, unstable collagen vascular diseases, etc.)
  • •5\. Disabling physical conditions
  • •6\. Pregnant or nursing women
  • •7\. Unable to return for scheduled follow\-up visits
  • •8\. Unable to understand protocol
  • •Second Phase

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
PROSPECTIVE, TRIAL EVALUATING THE SAFETY AND EFFECTIVENESS OF THE INTERSCOPE ENDOROTOR® RESECTION SYSTEM FOR DIRECT ENDOSCOPIC NECROSECTOMY OF WALLED OFF PANCREATIC NECROSISencapsulated pancreatic necrosiswalled-off pancreatic necrosis10017998
NL-OMON47969Interscope Medical, Inc.5
Active, not recruiting
Not Applicable
A Prospective Trial to Assess the Safety and Performance of the Spinal Modulation Neurostimulator System in the Treatment of Chronic PaiChronic Neuropathic PainAnaesthesiology - Pain managementMusculoskeletal - Other muscular and skeletal disorders
ACTRN12610001062011Spinal Modulation30
Completed
Not Applicable
A Prospective Trial to Assess the Safety and Performance of the Spinal Modulation Neurostimulator System in the Treatment of Chronic PaiChronic intractable pain
NL-OMON36763Spinal Modulation35
Not yet recruiting
Phase 2
STUDY COMPARISON OF EFFICACY OF LEVETIRACETAM ANDMAGNESIUM SULPHATE IN THE MANAGEMENT OF ANTEPARTUM, INTRAPARTUM AND POSTPARTUM CONVULSIONSHealth Condition 1: O159- Eclampsia, unspecified as to timeperiod
CTRI/2021/04/032963Dr Sindhu Manne
Completed
Not Applicable
Study to Evaluate the Safety and Efficacy of Levetiracetam in Comparison To Magnesium Sulphate in the Management of Severe Pre â?? Eclampsia
CTRI/2020/02/023194BLDE Deemed to be University30